Nanomedicine could revolutionise the way we treat TB. Here’s how
At present, TB patients have to take multiple pills a day, often with significant side effects. Image: REUTERS/Mariana Bazo
Sarah D'Souza
Postdoctoral Fellow in the Tuberculosis Nanomedicine Research Group, University of the Western Cape
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
Precision Medicine
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on Precision MedicineSee all
Ruth Itzhaki
November 24, 2022
Pattra Chun-On and Jonathan Alder
November 23, 2022
Gabriele Lignani and Dimitri Kullmann
November 18, 2022
Andrea Sturchio, Kariem Ezzat and Samir EL Andaloussi
October 19, 2022
Kevin Doxzen
October 18, 2022
Douglas Broom
October 5, 2022